[1]
|
程少浩, 苏艳军, 程若川. TgAb干扰血清Tg检测的相关因素研究进展[J]. 山东医药, 2021, 61(11): 85-88.
|
[2]
|
彭朝艳, 廖延, 王睿, 等. 甲状腺球蛋白测定在甲状腺癌中的应用及研究进展[J]. 标记免疫分析与临床, 2021, 28(7): 1253-1257.
|
[3]
|
Latrofa, F., Ricci, D., Bottai, S., et al. (2018) Effect of Thyroglobulin Autoantibodies on the Metabolic Clearance of Serum Thyroglobulin. Thyroid, 28, 288-294. https://doi.org/10.1089/thy.2017.0052
|
[4]
|
Weigle, W.O. and High, G.J. (1967) The Behavior of Autologous Thyroglobulin in the Circulation of Rabbits Immunized with Either Heterologous or Altered Homologous Thyroglobulin. The Journal of Immunology, 98, 1105-1114.
|
[5]
|
Algeciras-Schimnich, A. (2018) Thyroglobulin Measurement in the Management of Patients with Differentiated Thyroid Cancer. Critical Reviews in Clinical Laboratory Sciences, 55, 205-218.
https://doi.org/10.1080/10408363.2018.1450830
|
[6]
|
Spencer, C. and Fatemi, S. (2013) Thyroglobulin Antibody (TgAb) Methods—Strengths, Pitfalls and Clinical Utility for Monitoring TgAb-Positive Patients with Differentiated Thyroid Cancer. Best Practice & Research Clinical Endocrinology & Metabolism, 27, 701-712. https://doi.org/10.1016/j.beem.2013.07.003
|
[7]
|
Spencer, C., LoPresti, J. and Fatemi, S. (2014) How Sensitive (Second-Generation) Thyroglobulin Measurement Is Changing Paradigms for Monitoring Patients with Differentiated Thyroid Cancer, in the Absence or Presence of Thyroglobulin Autoantibodies. Current Opinion in Endocrinology, Dia-betes and Obesity, 21, 394-404.
https://doi.org/10.1097/MED.0000000000000092
|
[8]
|
Demers, L.M. and Spencer, C.A. (2003) Laboratory Medi-cine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. Clinical Endocri-nology, 58, 138-140.
https://doi.org/10.1046/j.1365-2265.2003.01681.x
|
[9]
|
Spencer, C.A., Bergoglio, L.M., Kazarosyan, M., et al. (2005) Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas. The Journal of Clinical Endocrinology & Metabolism, 90, 5566-5575. https://doi.org/10.1210/jc.2005-0671
|
[10]
|
Netzel, B.C., Grebe, S.K., Carranza, L.B., et al. (2015) Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results with Clinical Outcomes. The Journal of Clinical Endocrinology & Metabolism, 100, E1074-E1083. https://doi.org/10.1210/jc.2015-1967
|
[11]
|
Azmat, U., Porter, K., Senter, L., et al. (2017) Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sen-sitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies. Thyroid, 27, 74-80.
https://doi.org/10.1089/thy.2016.0210
|
[12]
|
Clark, P.M. (2009) Laboratory Services for Thyroglobulin and Impli-cations for Monitoring of Differentiated Thyroid Cancer. Journal of Clinical Pathology, 62, 402-406. https://doi.org/10.1136/jcp.2008.058024
|
[13]
|
Cunha, N., Rodrigues, F., Curado, F., et al. (2007) Thyroglobulin Detection in Fine-Needle Aspirates of Cervical Lymph Nodes: A Technique for the Diagnosis of Metastatic Differentiat-ed Thyroid Cancer. European Journal of Endocrinology, 157, 101-107. https://doi.org/10.1530/EJE-07-0088
|
[14]
|
van der Laken, C.J., Voskuyl, A.E., Roos, J.C., et al. (2007) Imaging and Serum Analysis of Immune Complex Formation of Radiolabelled Infliximab and Anti-Infliximab in Responders and Non-Responders to Therapy for Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 66, 253-256. https://doi.org/10.1136/ard.2006.057406
|
[15]
|
Spencer, C.A. and Lopresti, J.S. (2008) Measuring Thyroglobulin and Thyroglobulin Autoantibody in Patients with Differentiated Thyroid Cancer. Nature Clinical Practice. Endocrinology & Metabolism, 4, 223-233.
https://doi.org/10.1038/ncpendmet0757
|
[16]
|
Spencer, C.A. (2011) Clinical Review: Clinical Utility of Thyroglobu-lin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC). The Journal of Clinical Endocrinology and Metabolism, 96, 3615-3627.
https://doi.org/10.1210/jc.2011-1740
|
[17]
|
Cooper, D.S., Doherty, G.M., Haugen, B.R., et al. (2009) Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 19, 1167-1214.
https://doi.org/10.1089/thy.2009.0110
|
[18]
|
Kim, E.S., Lim, D.J., Baek, K.H., et al. (2010) Thyroglobulin Anti-body Is Associated with Increased Cancer Risk in Thyroid Nodules. Thyroid, 20, 885-891. https://doi.org/10.1089/thy.2009.0384
|
[19]
|
Vasileiadis, I., Boutzios, G., Charitoudis, G., et al. (2014) Thyroglobu-lin Antibodies Could Be a Potential Predictive Marker for Papillary Thyroid Carcinoma. Annals of Surgical Oncology, 21, 2725-2732.
https://doi.org/10.1245/s10434-014-3593-x
|
[20]
|
Hosseini, S., Payne, R.J., Zawawi, F., et al. (2016) Can Preoper-ative Thyroglobulin Antibody Levels be Used as a Marker for Well Differentiated Thyroid Cancer? Journal of Otolaryn-gology—Head & Neck Surgery, 45, Article No. 31. https://doi.org/10.1186/s40463-016-0143-5
|
[21]
|
Kim, W.G., Yoon, J.H., Kim, W.B., et al. (2008) Change of Serum Antithyroglobulin Antibody Levels Is Useful for Prediction of Clinical Recurrence in Thyroglobulin-Negative Patients with Differentiated Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism, 93, 4683-4689. https://doi.org/10.1210/jc.2008-0962
|
[22]
|
Feldt-Rasmussen, U., Blichert-Toft, M., Christiansen, C., et al. (1982) Serum Thyroglobulin and Its Autoantibody Following Subtotal Thyroid Resection of Graves’ Disease. European Journal of Clinical Investigation, 12, 203-208.
https://doi.org/10.1111/j.1365-2362.1982.tb00994.x
|
[23]
|
Chiovato, L., Latrofa, F., Braverman, L.E., et al. (2003) Disappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens. Annals of Internal Medicine, 139, 346-351.
https://doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00010
|
[24]
|
Gorges, R., Maniecki, M., Jentzen, W., et al. (2005) Development and Clinical Impact of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Car-cinoma during the First 3 Years after Thyroidectomy. European Journal of Endocrinology, 153, 49-55. https://doi.org/10.1530/eje.1.01940
|
[25]
|
Matrone, A., Latrofa, F., Torregrossa, L., et al. (2018) Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy without 131I Ablation. Thyroid, 28, 871-879.
https://doi.org/10.1089/thy.2018.0080
|
[26]
|
Durante, C., Tognini, S., Montesano, T., et al. (2014) Clinical Aggres-siveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoan-tibodies. Thyroid, 24, 1139-1145.
https://doi.org/10.1089/thy.2013.0698
|
[27]
|
张娜, 林岩松, 梁军. 甲状腺球蛋白抗体测定在分化型甲状腺癌131I治疗中的临床意义[J]. 中国癌症杂志, 2019, 29(6): 452-456.
|
[28]
|
Ozkan, E., Soydal, C., Araz, M., et al. (2012) The Additive Clinical Value of 18F-FDG PET/CT in Defining the Recurrence of Disease in Patients with Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels. Clinical Nuclear Medicine, 37, 755-758. https://doi.org/10.1097/RLU.0b013e31825ae77b
|
[29]
|
Slifka, M.K., Antia, R., Whitmire, J.K., et al. (1998) Humoral Immunity Due to Long-Lived Plasma Cells. Immunity, 8, 363-372. https://doi.org/10.1016/S1074-7613(00)80541-5
|
[30]
|
Chung, J.K., Park, Y.J., Kim, T.Y., et al. (2002) Clinical Significance of Elevated Level of Serum Antithyroglobulin Antibody in Patients with Differentiated Thyroid Cancer after Thyroid Ablation. Clinical Endocrinology, 57, 215-221.
https://doi.org/10.1046/j.1365-2265.2002.01592.x
|
[31]
|
Nixon, I.J., Whitcher, M.M., Palmer, F.L., et al. (2012) The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland. Thyroid, 22, 884-889.
https://doi.org/10.1089/thy.2011.0535
|
[32]
|
Spencer, C. (2013) Commentary on: Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement. Thyroid, 23, 1190-1192. https://doi.org/10.1089/thy.2013.0496
|
[33]
|
Trimboli, P., Zilioli, V., Imperiali, M., et al. (2017) Thy-roglobulin Autoantibodies before Radioiodine Ablation Predict Differentiated Thyroid Cancer Outcome. Clinical Chem-istry and Laboratory Medicine, 55, 1995-2001.
https://doi.org/10.1515/cclm-2017-0033
|
[34]
|
Seo, J.H., Lee, S.W., Ahn, B.C., et al. (2010) Recurrence Detection in Differentiated Thyroid Cancer Patients with Elevated Serum Level of Antithyroglobulin Antibody: Special Emphasis on Using (18)F-FDG PET/CT. Clinical Endocrinology, 72, 558-563. https://doi.org/10.1111/j.1365-2265.2009.03693.x
|
[35]
|
Chai, H., Zhu, Z.J., Chen, Z.Q., et al. (2016) Diagnostic Value of Tg and TgAb for Metastasis Following Ablation in Patients with Differentiated Thyroid Carcinoma Coexistent with Hashimoto Thyroiditis. Endocrine Research, 41, 218-222. https://doi.org/10.3109/07435800.2015.1010210
|
[36]
|
Grani, G., Calvanese, A., Carbotta, G., et al. (2015) Thyroid Autoimmunity and Risk of Malignancy in Thyroid Nodules Submitted to Fine-Needle Aspiration Cytology. Head & Neck, 37, 260-264. https://doi.org/10.1002/hed.23587
|
[37]
|
Gianoukakis, A.G. (2015) Thyroglobulin Antibody Status and Differentiated Thyroid Cancer: What Does It Mean for Prognosis and Surveillance? Current Opinion in On-cology, 27, 26-32.
https://doi.org/10.1097/CCO.0000000000000149
|
[38]
|
Haugen, B.R., Alexander, E.K., Bible, K.C., et al. (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thy-roid Cancer. Thyroid, 26, 1-133.
https://doi.org/10.1089/thy.2015.0020
|
[39]
|
Pacini, F., Mariotti, S., Formica, N., et al. (1988) Thyroid Autoanti-bodies in Thyroid Cancer: Incidence and Relationship with Tumour Outcome. Acta Endocrinologica, 119, 373-380. https://doi.org/10.1530/acta.0.1190373
|
[40]
|
Li, C., Yu, W., Fan, J., et al. (2016) Thyroid Functional Parameters and Correlative Autoantibodies as Prognostic Factors for Differentiated Thyroid Cancers. Oncotarget, 7, 49930-49938. https://doi.org/10.18632/oncotarget.10236
|
[41]
|
Alexandru, D., Glantz, M.J., Kim, L., et al. (2011) Pulmonary Metastases in Patients with Recurrent, Treatment-Resistant Meningioma: Prognosis and Identification by 111Indium-Octreotide Imaging. Cancer, 117, 4506-4511.
https://doi.org/10.1002/cncr.26065
|
[42]
|
Lee, Z., Eslick, G.D. and Edirimanne, S. (2020) Investigating Antithy-roglobulin Antibody as a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic Review. Thyroid, 30, 1601-1612.
https://doi.org/10.1089/thy.2019.0368
|